{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:20Z","timestamp":1789560140224,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41443-024-00951-1","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T14:02:14Z","timestamp":1722088934000},"page":"647-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A narrative review of initial treatment for ischemic priapism"],"prefix":"10.1038","volume":"38","author":[{"given":"Supanut","family":"Lumbiganon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5396-1364","authenticated-orcid":false,"given":"Muhammed A.","family":"Moukhtar Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-4034","authenticated-orcid":false,"given":"Babak","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9408-482X","authenticated-orcid":false,"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"key":"951_CR1","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/JU.0000000000002236","volume":"206","author":"TJ Bivalacqua","year":"2021","unstructured":"Bivalacqua TJ, Allen BK, Brock G, Broderick GA, Kohler TS, Mulhall JP, et al. Acute ischemic priapism: an AUA\/SMSNA guideline. J Urol. 2021;206:1114\u201321.","journal-title":"J Urol"},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/00365599509180545","volume":"29","author":"RV Kulmala","year":"1995","unstructured":"Kulmala RV, Lehtonen TA, Tammela TL. Priapism, its incidence and seasonal distribution in Finland. Scand J Urol Nephrol. 1995;29:93\u20136.","journal-title":"Scand J Urol Nephrol"},{"key":"951_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","volume":"57","author":"IA Eland","year":"2001","unstructured":"Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology. 2001;57:970\u20132.","journal-title":"Urology"},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/jsm.12251","volume":"10","author":"DM Stein","year":"2013","unstructured":"Stein DM, Flum AS, Cashy J, Zhao LC, McVary KT. Nationwide emergency department visits for priapism in the United States. J Sex Med. 2013;10:2418\u201322.","journal-title":"J Sex Med"},{"key":"951_CR5","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jsxm.2019.09.012","volume":"16","author":"M Cintho Ozahata","year":"2019","unstructured":"Cintho Ozahata M, Page GP, Guo Y, Ferreira JE, Dinardo CL, Carneiro-Proietti ABF, et al. Clinical and genetic predictors of priapism in sickle cell disease: results from the recipient epidemiology and donor evaluation study III Brazil cohort study. J Sex Med. 2019;16:1988\u201399.","journal-title":"J Sex Med"},{"key":"951_CR6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","volume":"90","author":"AB Adeyoju","year":"2002","unstructured":"Adeyoju AB, Olujohungbe ABK, Morris J, Yardumian A, Bareford D, Akenova A, et al. Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study. BJU Int. 2002;90:898\u2013902.","journal-title":"BJU Int"},{"key":"951_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","volume":"7","author":"GA Broderick","year":"2010","unstructured":"Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476\u2013500. 1 Pt 2.","journal-title":"J Sex Med"},{"key":"951_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.ijir.3901231","volume":"17","author":"A Muneer","year":"2005","unstructured":"Muneer A, Cellek S, Dogan A, Kell PD, Ralph DJ, Minhas S. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res. 2005;17:10\u20138.","journal-title":"Int J Impot Res"},{"key":"951_CR9","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jsxm.2019.05.011","volume":"16","author":"M Orta\u00e7","year":"2019","unstructured":"Orta\u00e7 M, \u00c7evik G, Akdere H, Erme\u00e7 B, Kad\u0131o\u011flu A. Anatomic and functional outcome following distal shunt and tunneling for treatment i\u0307schemic priapism: a single-center experience. J Sex Med. 2019;16:1290\u20136.","journal-title":"J Sex Med"},{"key":"951_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/0974-7796.165717","volume":"8","author":"DK Pal","year":"2016","unstructured":"Pal DK, Biswal DK, Ghosh B. Outcome and erectile function following treatment of priapism: an institutional experience. Urol Ann. 2016;8:46\u201350.","journal-title":"Urol Ann"},{"key":"951_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","volume":"80","author":"A Salonia","year":"2021","unstructured":"Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of Urology guidelines on sexual and reproductive health\u20142021 update: male sexual dysfunction. Eur Urol. 2021;80:333\u201357.","journal-title":"Eur Urol"},{"key":"951_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","volume":"21","author":"E Mantadakis","year":"1999","unstructured":"Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 1999;21:518\u201322.","journal-title":"J Pediatr Hematol Oncol"},{"key":"951_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-5347(17)38248-4","volume":"145","author":"JE Fowler","year":"1991","unstructured":"Fowler JE, Koshy M, Strub M, Chinn SK. Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol. 1991;145:65\u20138.","journal-title":"J Urol"},{"key":"951_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3346\/jkms.1993.8.3.202","volume":"8","author":"SC Kim","year":"1993","unstructured":"Kim SC, Seo KK, Oh CH. Corporeal blood gas changes according to duration of drug-induced prolonged erection. J Korean Med Sci. 1993;8:202\u20136.","journal-title":"J Korean Med Sci"},{"key":"951_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.purol.2021.03.009","volume":"32","author":"S Wakrim","year":"2022","unstructured":"Wakrim S, Ziouziou I, Ralph D, Khabbal Y. Penile Doppler ultrasound study in priapism: a systematic review. Prog Urol. 2022;32:61\u20139.","journal-title":"Prog Urol"},{"key":"951_CR16","doi-asserted-by":"publisher","first-page":"611.e9","DOI":"10.1016\/j.crad.2017.02.021","volume":"72","author":"C von Stempel","year":"2017","unstructured":"von Stempel C, Zacharakis E, Allen C, Ramachandran N, Walkden M, Minhas S, et al. Mean velocity and peak systolic velocity can help determine ischaemic and non-ischaemic priapism. Clin Radiol. 2017;72:611.e9\u2013611.e16.","journal-title":"Clin Radiol"},{"key":"951_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajem.2015.10.029","volume":"34","author":"C Martin","year":"2016","unstructured":"Martin C, Cocchio C. Effect of phenylephrine and terbutaline on ischemic priapism: a retrospective review. Am J Emerg Med. 2016;34:222\u20134.","journal-title":"Am J Emerg Med"},{"key":"951_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4081\/aiua.2017.3.203","volume":"89","author":"MG S\u00f6nmez","year":"2017","unstructured":"S\u00f6nmez MG, \u00d6zt\u00fcrk S\u00f6nmez L, Ta\u015fkapu HH, Kara C, D\u00fcndar ZD, G\u00f6\u011fer YE, et al. Etiological factors and management in priapism patients and attitude of emergency physicians. Arch Ital Urol Androl. 2017;89:203\u20137.","journal-title":"Arch Ital Urol Androl"},{"key":"951_CR19","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1743-6109.2008.00770.x","volume":"5","author":"N Bennett","year":"2008","unstructured":"Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med. 2008;5:1244\u201350.","journal-title":"J Sex Med"},{"key":"951_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.juro.2013.07.034","volume":"191","author":"E Zacharakis","year":"2014","unstructured":"Zacharakis E, Raheem AA, Freeman A, Skolarikos A, Garaffa G, Christopher AN, et al. The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J Urol. 2014;191:164\u20138.","journal-title":"J Urol"},{"key":"951_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41443-022-00592-2","volume":"36","author":"P Capogrosso","year":"2002","unstructured":"Capogrosso P, Dimitropolous K, Russo GI, Tharakan T, Milenkovic U, Cocci A. et al. Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel. Int J Impot Res. 2002;36:6\u201319.","journal-title":"Int J Impot Res"},{"key":"951_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0090-4295(93)90338-B","volume":"42","author":"FC Lowe","year":"1993","unstructured":"Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993;42:51\u20133. discussion 53-54","journal-title":"Urology"},{"key":"951_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/0974-7796.176874","volume":"8","author":"M Habous","year":"2016","unstructured":"Habous M, Elkhouly M, Abdelwahab O, Farag M, Madbouly K, Altuwaijri T, et al. Noninvasive treatments for iatrogenic priapism: Do they really work? A prospective multicenter study. Urol Ann. 2016;8:193\u20136.","journal-title":"Urol Ann"},{"key":"951_CR24","doi-asserted-by":"crossref","unstructured":"Bochinski DJ, Deng DY, Lue TF. The treatment of priapism-when and how? Int J Impot Res. 2003;15:S86\u201390.","DOI":"10.1038\/sj.ijir.3901078"},{"key":"951_CR25","doi-asserted-by":"crossref","unstructured":"Traish A, Kim NN, Moreland RB, Goldstein I. Role of alpha-adrenergic receptors in erectile function. Int J Impot Res. 2000;12:S48\u201363.","DOI":"10.1038\/sj.ijir.3900506"},{"key":"951_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.21037\/tau.2017.07.23","volume":"6","author":"AB Reed-Maldonado","year":"2017","unstructured":"Reed-Maldonado AB, Kim JS, Lue TF. Avoiding complications: surgery for ischemic priapism. Transl Androl Urol. 2017;6:657\u201365.","journal-title":"Transl Androl Urol"},{"key":"951_CR27","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1743-6109.2005.00140.x","volume":"3","author":"CC Wen","year":"2006","unstructured":"Wen CC, Munarriz R, McAuley I, Goldstein I, Traish A, Kim N. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med. 2006;3:918\u201322.","journal-title":"J Sex Med"},{"key":"951_CR28","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/j.1743-6109.2008.00862.x","volume":"5","author":"A Muneer","year":"2008","unstructured":"Muneer A, Minhas S, Freeman A, Kumar P, Ralph DJ. Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. J Sex Med. 2008;5:2152\u20139.","journal-title":"J Sex Med"},{"key":"951_CR29","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jsxm.2018.05.012","volume":"15","author":"AS Sidhu","year":"2018","unstructured":"Sidhu AS, Wayne GF, Kim BJ, Anderson AGS, Cordon BH, Caso JR, et al. The hemodynamic effects of intracavernosal phenylephrine for the treatment of ischemic priapism. J Sex Med. 2018;15:990\u20136.","journal-title":"J Sex Med"},{"key":"951_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","volume":"47","author":"R Virag","year":"1996","unstructured":"Virag R, Bachir D, Lee K, Galacteros F. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology. 1996;47:777\u201381. discussion 781","journal-title":"Urology"},{"key":"951_CR31","first-page":"247","volume":"85","author":"L Cormio","year":"1996","unstructured":"Cormio L, Nis\u00e9n H, Ruutu M, Selvaggi FP. Etilefrine in the prevention of prolonged erection after diagnostic pharmacological stimulation. Ann Chir Gynaecol. 1996;85:247\u201350.","journal-title":"Ann Chir Gynaecol"},{"key":"951_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/adc.85.1.52","volume":"85","author":"AD Gbado\u00e9","year":"2001","unstructured":"Gbado\u00e9 AD, Atakouma Y, Kusiaku K, Assimadi JK. Management of sickle cell priapism with etilefrine. Arch Dis Child. 2001;85:52\u20133.","journal-title":"Arch Dis Child"},{"key":"951_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/sj.ijir.3900539","volume":"12","author":"D Keskin","year":"2000","unstructured":"Keskin D, Cal C, Deliba\u015f M, Ozyurt C, G\u00fcnaydin G, Nazli O, et al. Intracavernosal adrenalin injection in priapism. Int J Impot Res. 2000;12:312\u20134.","journal-title":"Int J Impot Res"},{"key":"951_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jemermed.2007.10.051","volume":"36","author":"JR Roberts","year":"2009","unstructured":"Roberts JR, Price C, Mazzeo T. Intracavernous epinephrine: a minimally invasive treatment for priapism in the emergency department. J Emerg Med. 2009;36:285\u20139.","journal-title":"J Emerg Med"},{"key":"951_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1182\/blood.V95.1.78","volume":"95","author":"E Mantadakis","year":"2000","unstructured":"Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000;95:78\u201382.","journal-title":"Blood"},{"key":"951_CR36","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0022-5347(01)67545-1","volume":"153","author":"M Lee","year":"1995","unstructured":"Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. J Urol. 1995;153:1182\u20133.","journal-title":"J Urol"},{"key":"951_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1464-4096.2001.01510.x","volume":"89","author":"MS El-Bahnasawy","year":"2002","unstructured":"El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int. 2002;89:285\u201390.","journal-title":"BJU Int"},{"key":"951_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(84)90500-2","volume":"2","author":"GS Brindley","year":"1984","unstructured":"Brindley GS. New treatment for priapism. Lancet. 1984;2:220\u20131.","journal-title":"Lancet"},{"key":"951_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0018578718778230","volume":"54","author":"RDR Palagiri","year":"2019","unstructured":"Palagiri RDR, Chatterjee K, Jillella A, Hammond DA. A case report of hypertensive emergency and intracranial hemorrhage due to intracavernosal Phenylephrine. Hosp Pharm. 2019;54:186\u20139.","journal-title":"Hosp Pharm"},{"key":"951_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jemermed.2017.01.055","volume":"52","author":"ST Constantine","year":"2017","unstructured":"Constantine ST, Gopalsami A, Helland G. Recurrent priapism gone wrong: ST-elevation myocardial infarction and cardiogenic shock after penile corporal phenylephrine irrigation. J Emerg Med. 2017;52:859\u201362.","journal-title":"J Emerg Med"},{"key":"951_CR41","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1743-6109.2007.00715.x","volume":"5","author":"HH Davila","year":"2008","unstructured":"Davila HH, Parker J, Webster JC, Lockhart JL, Carrion RE. Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. J Sex Med. 2008;5:1025\u20138.","journal-title":"J Sex Med"},{"key":"951_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.ijir.3900308","volume":"10","author":"JD deHoll","year":"1998","unstructured":"deHoll JD, Shin PA, Angle JF, Steers WD. Alternative approaches to the management of priapism. Int J Impot Res. 1998;10:11\u20134.","journal-title":"Int J Impot Res"},{"key":"951_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1439-0272.1999.tb01451.x","volume":"31","author":"FJ Mart\u00ednez Portillo","year":"1999","unstructured":"Mart\u00ednez Portillo FJ, J\u00fcnemann KP. New aspects in the treatment of priapism. Andrologia. 1999;31:53\u20138.","journal-title":"Andrologia"},{"key":"951_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000052407","volume":"39","author":"F Mart\u00ednez Portillo","year":"2001","unstructured":"Mart\u00ednez Portillo F, Hoang-Boehm J, Weiss J, Alken P, J\u00fcnemann K. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol. 2001;39:20\u20133.","journal-title":"Eur Urol"},{"key":"951_CR45","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S0022-5347(05)66012-0","volume":"166","author":"S Rutchik","year":"2001","unstructured":"Rutchik S, Sorbera T, Rayford RW, Sullivan J. Successful treatment of recalcitrant priapism using intercorporeal injection of tissue plasminogen activator. J Urol. 2001;166:628.","journal-title":"J Urol"},{"key":"951_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/sj.ijir.3900759","volume":"13","author":"TH Bschleipfer","year":"2001","unstructured":"Bschleipfer TH, Hauck EW, Diemer TH, Bitzer M, Kirkpatrick Ch J, Pust RA, et al. Heparin-induced priapism. Int J Impot Res. 2001;13:357\u20139.","journal-title":"Int J Impot Res"},{"key":"951_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/01.ju.0000132155.38285.8e","volume":"172","author":"PH Lin","year":"2004","unstructured":"Lin PH, Bush RL, Lumsden AB. Low molecular weight heparin-induced priapism. J Urol. 2004;172:263.","journal-title":"J Urol"},{"key":"951_CR48","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jsxm.2020.07.013","volume":"17","author":"JJ Ramstein","year":"2020","unstructured":"Ramstein JJ, Lee A, Cohen AJ, Mmonu NA, Rios N, Enriquez A, et al. Clinical outcomes of periprocedural antithrombotic therapy in ischemic priapism management. J Sex Med. 2020;17:2260\u20136.","journal-title":"J Sex Med"},{"key":"951_CR49","doi-asserted-by":"publisher","unstructured":"Leong JY, Prebay ZJ, Ebbott D, Li M, Chung PH. Evaluating the management trends for priapism and assessing the risk of priapism after in-office intracavernosal injections: a cross-sectional analysis. Int J Impot Res. 2024; https:\/\/doi.org\/10.1038\/s41443-024-00861-2.","DOI":"10.1038\/s41443-024-00861-2"},{"key":"951_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6214921","volume":"2019","author":"JP Saffon Cuartas","year":"2019","unstructured":"Saffon Cuartas JP, Sandoval-Salinas C, Mart\u00ednez JM, Corredor HA. Treatment of priapism secondary to drugs for erectile dysfunction. Adv Urol. 2019;2019:e6214921.","journal-title":"Adv Urol"},{"key":"951_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41443-022-00583-3","volume":"36","author":"N Schifano","year":"2024","unstructured":"Schifano N, Capogrosso P, Boeri L, Fallara G, Cakir OO, Castiglione F, et al. Medications mostly associated with priapism events: assessment of the 2015\u20132020 Food and Drug Administration (FDA) pharmacovigilance database entries. Int J Impot Res. 2024;36:50\u20134.","journal-title":"Int J Impot Res"},{"key":"951_CR52","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/SMJ.0b013e3181c04775","volume":"102","author":"S Koirala","year":"2009","unstructured":"Koirala S, Penagaluri P, Smith C, Lippmann S. Priapism and risperidone. South Med J. 2009;102:1266\u20138.","journal-title":"South Med J"},{"key":"951_CR53","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jsxm.2020.05.019","volume":"17","author":"ME Rezaee","year":"2020","unstructured":"Rezaee ME, Gross MS. Are we overstating the risk of priapism with oral phosphodiesterase type 5 inhibitors? J Sex Med. 2020;17:1579\u201382.","journal-title":"J Sex Med"},{"key":"951_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1345\/aph.1E383","volume":"39","author":"L Galatti","year":"2005","unstructured":"Galatti L, Fioravanti A, Salvo F, Polimeni G, Giustini SE. Interaction between tadalafil and itraconazole. Ann Pharmacother. 2005;39:200\u2013200.","journal-title":"Ann Pharmacother"},{"key":"951_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1023\/B:UROL.0000025617.97048.ae","volume":"35","author":"J H\u00fcbler","year":"2003","unstructured":"H\u00fcbler J, Sz\u00e1nt\u00f3 A, K\u00f6nyves K. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol. 2003;35:519\u201321.","journal-title":"Int Urol Nephrol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00951-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00951-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00951-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:04:05Z","timestamp":1789556645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00951-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1038\/s41443-024-00951-1","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"7 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}